×
About 3,315 results

ALLMedicine™ Medullary Thyroid Carcinoma Center

Research & Reviews  1,633 results

PET imaging in medullary thyroid carcinoma: time for reappraisal?
https://doi.org/10.1089/thy.2020.0674
Thyroid : Official Journal of the American Thyroid Association; Taïeb D, Castinetti F

Nov 16th, 2020 - Medullary thyroid carcinomas (MTC) are rare neoplasms derived from calcitonin-secreting cells of the thyroid. They can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndromes. Overall, successful management of MTC patien...

Impact of gastrointestinal symptoms on quality of life in MEN2.
https://doi.org/10.1111/cen.14366
Clinical Endocrinology; Goncharova M, Grey J et. al.

Nov 10th, 2020 - Besides medullary thyroid carcinoma and other endocrinopathies, people with Multiple Endocrine Neoplasia Type 2 (MEN2) are at risk of gastrointestinal (GI) symptoms. To investigate the impact of GI symptoms on the daily lives of patients with MEN2...

Pralsetinib: First Approval.
https://doi.org/10.1007/s40265-020-01427-4
Drugs Markham A

Nov 2nd, 2020 - Pralsetinib (GAVRETO™, Blueprint Medicines Corporation) is a selective rearranged during transfection (RET) inhibitor being developed for the treatment of various solid tumours. RET is a well described proto-oncogene present in multiple cancers in...

Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Dec...
https://doi.org/10.1089/thy.2020.0167
Thyroid : Official Journal of the American Thyroid Association; Kotwal A, Erickson D et. al.

Oct 28th, 2020 - Medullary thyroid cancer (MTC) can be associated with significant morbidity and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC surgery to predict overall survival (OS), disease-specific survival (DSS), loco-reg...

Nodal disease burden and outcome of medullary thyroid carcinoma.
https://doi.org/10.1002/hed.26511
Head & Neck REFERENCES; Moses LE, Oliver JR et. al.

Oct 27th, 2020 - Medullary thyroid carcinoma (MTC) is a rare malignancy with high incidence of cervical lymph node (CLN) metastasis. We investigated the impact of nodal disease burden on survival. We searched the National Cancer Database for MTC patients treated s...

see more →

Guidelines  2 results

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Workin...
https://doi.org/10.1007/s12094-015-1465-x
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico; Grande E, Santamaría Sandi J et. al.

Dec 21st, 2015 - Of all thyroid cancers, <5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays a central role on its pathogeny. The electronic search was conducted using MEDLINE (Pub...

Revised American Thyroid Association guidelines for the management of medullary thyroid...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490627
Thyroid : Official Journal of the American Thyroid Association; Wells SA, Asa SL et. al.

Mar 26th, 2015 - The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. The Task Force identified relevant articles using a systematic PubMed...

see more →

Clinicaltrials.gov  1,659 results

PET imaging in medullary thyroid carcinoma: time for reappraisal?
https://doi.org/10.1089/thy.2020.0674
Thyroid : Official Journal of the American Thyroid Association; Taïeb D, Castinetti F

Nov 16th, 2020 - Medullary thyroid carcinomas (MTC) are rare neoplasms derived from calcitonin-secreting cells of the thyroid. They can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndromes. Overall, successful management of MTC patien...

Impact of gastrointestinal symptoms on quality of life in MEN2.
https://doi.org/10.1111/cen.14366
Clinical Endocrinology; Goncharova M, Grey J et. al.

Nov 10th, 2020 - Besides medullary thyroid carcinoma and other endocrinopathies, people with Multiple Endocrine Neoplasia Type 2 (MEN2) are at risk of gastrointestinal (GI) symptoms. To investigate the impact of GI symptoms on the daily lives of patients with MEN2...

Pralsetinib: First Approval.
https://doi.org/10.1007/s40265-020-01427-4
Drugs Markham A

Nov 2nd, 2020 - Pralsetinib (GAVRETO™, Blueprint Medicines Corporation) is a selective rearranged during transfection (RET) inhibitor being developed for the treatment of various solid tumours. RET is a well described proto-oncogene present in multiple cancers in...

Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Dec...
https://doi.org/10.1089/thy.2020.0167
Thyroid : Official Journal of the American Thyroid Association; Kotwal A, Erickson D et. al.

Oct 28th, 2020 - Medullary thyroid cancer (MTC) can be associated with significant morbidity and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC surgery to predict overall survival (OS), disease-specific survival (DSS), loco-reg...

Nodal disease burden and outcome of medullary thyroid carcinoma.
https://doi.org/10.1002/hed.26511
Head & Neck REFERENCES; Moses LE, Oliver JR et. al.

Oct 27th, 2020 - Medullary thyroid carcinoma (MTC) is a rare malignancy with high incidence of cervical lymph node (CLN) metastasis. We investigated the impact of nodal disease burden on survival. We searched the National Cancer Database for MTC patients treated s...

see more →

News  21 results

BLU-667: New Hope for NSCLC and Medullary Thyroid Cancer
https://www.staging.medscape.com/viewarticle/895225

Apr 15th, 2018 - CHICAGO — Point mutations or gene rearrangements in the receptor tyrosine kinase proto-oncogene RET have been seen in several tumors, including medullary thyroid carcinoma (MTC) and non–small cell lung cancer (NSCLC). However, there are no approve...

BLU-667: New Hope for NSCLC and Medullary Thyroid Cancer
https://www.medscape.com/viewarticle/895225

Apr 15th, 2018 - CHICAGO — Point mutations or gene rearrangements in the receptor tyrosine kinase proto-oncogene RET have been seen in several tumors, including medullary thyroid carcinoma (MTC) and non–small cell lung cancer (NSCLC). However, there are no approve...

Scapular rash and endocrine neoplasia
https://www.mdedge.com/ccjm/article/150352/dermatology/scapular-rash-and-endocrine-neoplasia?channel=162
Muhammed Razmi T, MD, DNB, Debajyoti Chatterjee, MD et. al.

Nov 1st, 2017 - A woman in her 30s presented with an itchy skin-colored rash over her left scapular region that had first appeared 8 years earlier. It had started as itchy skin-colored papules that coalesced to a patch and later became hyperpigmented because of r.

Thyroid Ca: Initial Neck Dissection May Cut Recurrence Risk
https://www.medpagetoday.com/endocrinology/thyroid/68165

Sep 27th, 2017 - Action Points Among those with medullary thyroid carcinoma (MTC), lymph node dissection seemed to decrease local recurrences. Note that guidelines from the American Thyroid Association recommend all patients with known MTC undergo surgery to remov...

Renal cell carcinoma approval adds another notch to cabozantinib’s belt
https://www.mdedge.com/hematology-oncology/article/118588/genitourinary-cancer/renal-cell-carcinoma-approval-adds-another
Edited by Jame Abraham, MD et. al.

Nov 21st, 2016 - In April this year, the US Food and Drug Administration awarded regulatory approval to cabozantinib for the treatment of advanced renal cell carcinoma patients previously treated with anti-angiogenic therapy. 1 The small-molecule inhibitor, which.

see more →